Dysregulation of c-MET signaling–mediated proliferation, migration, invasion and angiogenesis through overexpression of MET and amplification or mutation of the MET gene has been widely demonstrated in oncogenic processes across multiple tumor types [11,42]. This evidence concerns the gene MET and neoplasm.